期刊文献+

非酒精性脂肪肝患者血浆同型半胱氨酸水平测定及临床意义 被引量:7

Research on the plasma levels and the clinical significance of homocysteine in nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的探讨非酒精性脂肪性肝病(NAFLD)患者空腹血清同型半胱氨酸(Hcy)浓度变化的临床意义,同时探讨在NAFLD中Hcy浓度与叶酸及维生素B12浓度变化的相关性。方法对352例健康体检人群行B超检查,其中NAFLD组159例,正常对照组193例,分别检测血浆Hcy、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、叶酸与维生素B12浓度并进行相关性分析。结果 NAFLD患者血Hcy水平以及ALT、AST、TG、TC、HDL、LDL显著高于正常对照组(P<0.01),多因素Logistic回归分析显示ALT、TG、Hcy、LDL是NAFLD的主要危险因素,并且Hcy与叶酸、维生素B12呈直线负相关。结论 NAFLD患者血Hcy增高,高Hcy血症可能是NAFLD一个新的危险因素,在NAFLD发病中可能起重要作用。并且叶酸、维生素B12水平与Hcy水平具有相关性。 Objective To investigate the clinical significance of serum homocysteine(Hcy) in nonalcoholic fatty liver disease (NAFLD), to explore their correlations of Hcy, foliate and vitamin B12 in NAFLD. Methods B-ultrasound examination was performed on 352 individuals, of which 159 patients were confirmed with NAFLD and 193 patients served as controls. The plasma levels of Hcy, alanine aminotransferase (ALT), aspartate transaminase (AST), cholesterol total (TC), triglyceride (TG), high density lipoprotein(HDL), low density lipoprotein(LDL),folate and vitamin B12 were tested and their correlations were analyzed. Results The levels of Hcy and ALT, AST, TG, TC, HDL, LDL in NAFLD group were higher than that in normal group (P〈0. 01), and ALT, TG, Hcy, LDL were risk factors in NAFLD, an inverse linear correlation existed between the plasma levels of Hey and folate ,either between the plasma levels of Hcy and vitamin B12. Conclusion The plasma level of Hcy is enhanced in NAFLD patients, and Hyperhomocysteinemia(HHcy) may be a new risk factor in NAFLD. The levels of folate and vitamin B12 are correlated with Hcy.
出处 《国际消化病杂志》 CAS 2011年第3期166-169,共4页 International Journal of Digestive Diseases
关键词 非酒精性脂肪性肝病 同型半胱氨酸 叶酸 维生素B12 危险因素 Nonalcoholic fatty liver disease Homo cysteine Folate Vitamin B12 Risk factor
  • 相关文献

参考文献14

  • 1Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homoeysteine as a risk factor for vascular disease. Probable benefits of increasing folio acid intakes. JAMA, 1995, 274; 1049-1057.
  • 2沈雄文,孙国红,孙关忠,毛飞.肝损伤时血清同型半胱氨酸的浓度变化[J].中华肝脏病杂志,2003,11(4):242-242. 被引量:20
  • 3Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr, 1998, 157(Suppl 2) : S40-44.
  • 4Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e) inemia as a risk factor forocclusive vascular disease. Annu Rev Nutr, 1992, 12: 979-298.
  • 5非酒精性脂肪性肝病诊疗指南(2010年修订版).中华医学会肝脏病学分会脂肪肝和酒精性肝病学组[J].胃肠病学和肝病学杂志,2010,:483-487.
  • 6牛春峰,王新春,于汉力,许红丽.血清同型半胱氨酸浓度与冠心病相互关系的研究[J].中国危重病急救医学,2001,13(3):153-155. 被引量:15
  • 7de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol, 2008, 48 ( Suppl 1 ) : S104-S112.
  • 8Day C, Saksena S. Nonalcoholic steatohepatitis: definitions and pathogensis. J Gastroenterol Hepatol, 2002, 17: 377-384.
  • 9Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation, 1993, 87: 1107-1113.
  • 10范建高,郑晓英,张梅,杨兆瑞.非酒精性脂肪性肝病大鼠肝窦超微结构及微血栓观察[J].肝脏,2005,10(1):41-42. 被引量:18

二级参考文献8

共引文献82

同被引文献99

  • 1王晓蓉.冠心病患者检测同型半胱氨酸以及超敏C反应蛋白的临床价值[J].环球中医药,2013,6(S1):90-91. 被引量:3
  • 2吴乃君,魏剑芬,金秀平,陈冬.2型糖尿病患者高同型半胱氨酸血症与慢性血管并发症的关系[J].中国糖尿病杂志,2007,15(6):357-359. 被引量:23
  • 3毛福青 朱卫平.HCY与非酒精性脂肪性肝病相关性的研究.中外健康文摘,2011,:18-20.
  • 4FAN J G, FARRELL G C. Epidemiology of non-alcoholic fatty liver disease in China[J]. J Hepatol, 2009,50( 1 ) :204-210.
  • 5LEITE N C, SALLES G F, ARAUJO A L, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in pa- tients with type- 2 diabetes mellitus [ J ]. Liver Int, 2009,29 (1) :113-119.
  • 6GUPTA R, BHANGOO A, MATTHEWS N A, et al. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children [J]. J Pediatr Endocrinol Metab, 2011,24( 11 - 12) :907-911.
  • 7AMARAPURKAR D N, HASHIMOTO E, LESMANA L A, et al. How common is non-alcoholic fatty liver disease in the A-sia-Pacific region and are there local differences? [ J]. J Gastroenterol Hepatol, 2007,22 (6) :788- 793.
  • 8LU H, ZENG L, LIANG B, et al. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease[J]. Arch Med Res,2009,40(7) :571-575.
  • 9ANGULO P. GI epidemiology:nonaleoholie fatty liver disease [ J ]. Aliment Pharmacol Ther, 2007,25 ( 8 ) : 883- 889.
  • 10FAN J G, SAIBARA T, CHITTURI S, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in A- sia- Pacific? [ J ]. J Gastroenterol Hepatol, 2007,22 ( 6 ) : 794- 800.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部